Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000498583 | SCV000589788 | likely pathogenic | not provided | 2017-11-01 | criteria provided, single submitter | clinical testing | The c.807+2 T>G splice site variant in the SLC19A2 gene destroys the canonical splice donor site in intron 2. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. Although this variant has not been previously reported to our knowledge, it is predicted to be a likely pathogenic variant. |
Fulgent Genetics, |
RCV000762862 | SCV000893232 | likely pathogenic | Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness | 2018-10-31 | criteria provided, single submitter | clinical testing |